Sentences with phrase «price growth at»

Calgary starts will be hampered in the third quarter by the flooding earlier in the year, but as the «youngest» city in the survey, it is expected to enjoy the highest growth in starts and resale volumes in 2014, with price growth at a moderate level of two per cent to 3.5 per cent over the next few years.

«The main storyline in the early months of 2017 will be if supply can meaningfully increase to keep price growth at a moderate enough level for households to absorb higher borrowing costs.

«While national home prices increased 6.7 percent, only nine states had home price growth at the same rate of growth or higher than the national average because the largest states, such as Texas, Florida and California, are experiencing high rates of home price appreciation,» says Frank Nothaft, chief economist for CoreLogic.

Selling home properties for a gain over a short period of time usually demands humble price growth at minimum.

With property price growth at its lowest point in many years, 2018 will continue to be a great buying opportunity for property investors.

Quarter - over-quarter price growth at the national level posted 1 percent for the first time this year, while year - over-year growth posted an unchanged 6.3 percent.

An uptick in existing - home sales in the final three months of 2017 pulled down housing inventory to an all - time low and kept home - price growth at its recent robust pace.

Its price momentum has been consistent for the last half decade with one - year, three - year and five - year price growth at 12 %, 18 % and 17 %, respectively.

According to Realtors, an uptick in existing U.S. home sales in the final three months of 2017 pulled down housing inventory to an all - time low, while keeping home - price growth at its recent robust pace.

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

«The first thing to keep in mind is that, in some long run equilibrium, wage inflation should be equal to what the growth rate of productivity is — so how much workers can produce — and the increase in prices for the goods they produce,» he said at the UBS Greater China conference in Shanghai.

That's massive growth, no matter how you look at it, which helped push the stock price (NFLX) up by more than 139 % last year.

Currently, the company is trading at about 25 times earnings and with a long - term earnings per share growth rate of about 15 %, its price - to - earnings to growth ratio — a metric used to value fast growing companies — is about 1.4.

New Zealand's central bank recently announced new macro - prudential tools aimed at curbing high - velocity house price growth.

The terms and prices of variable annuities were much better before the financial crisis, but the rationale for a contract that guarantees an income stream while allowing for some participation in potential growth in the investment markets remains intact, according to Mark Cortazzo, senior partner at Macro Consulting Group.

Seeking to appease investors with boosts to share prices, CEOs are prioritizing short - term returns at the expense of R&D, workforce training and other investments essential to their companies» long - term growth.

In tandem, if wages do not rise at the rate of house - price growth, then buying a property becomes more and more unaffordable.

Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.

While the Kindle Fire can't match the success of the iPad yet, its startling growth shows it is a viable alternative tablet at a great price.

And even though much of the opportunity for further growth in the smartphone market is at the low end in emerging markets, don't expect Apple to go down in price much, Morgan Stanley analyst Katy Huberty said.

The reports looked strong at first, but looking under the hood, Cramer was very concerned by the weakness he saw: Kimberly - Clark, for one, is facing pricing challenges, rising commodity costs and a slumping diaper business in what had once been its best growth market: China.

Fortunately, while debt levels are rising they have not kept pace with the growth in real estate prices across the country — at least for now anyway.»

«Faster economic growth over most of the past year has tightened labor and product markets and helped to boost prices at a faster pace,» David Berson, chief economist at Nationwide, said in a note.

He points out that the double - digit growth much of the emerging market experienced in 2010 is over, so it's unlikely we'll see oil prices rise, at least in the short term.

It's clear that the growth is due to a confluence of factors: Welch's reputation and brand; a pragmatic education based on Welch's well - known dictums; the relatively low $ 39,000 price of the program (Indiana University's Kelley Direct program costs $ 66,000, while the University of North Carolina's MBA@UNC is priced at $ 99,700); and high levels of student satisfaction.

At the same time, consumers have seen only modest income growth, while prices for many things they buy — gasoline, groceries, clothes to name a few — have risen.

The risk is that the economy needs monetary policy tightened to cool prices before industrial activity and retail sales regain momentum lost last year as the Chinese economy delivered its slowest full year of growth since 1999, at 7.8 percent.

«We're looking for a growth business at a value price.»

«We're looking for a growth business but at a value price.»

Data from China's National Bureau of Statistics showed the consumer price index rose 3.2 percent in February from a year ago, versus expectations of a 3.0 percent rise, while annual industrial production (IP) growth in January and February combined at 9.9 percent was the lowest since October 2012 - the starting point of China's nascent economic recovery.

Williamson said the PMIs pointed to fourth - quarter GDP growth of 0.1 percent, weaker than the 0.2 percent predicted in a Reuters poll last week, but that very weak expansion is coming at a cost: firms cut prices for the 33rd month.

«Instead of growth at a reasonable price, it's dividend at a reasonable price,» says Anderson.

The economy at that time benefited from much higher rates of productivity growth, which allowed employers to raise pay and hire more without having to lift prices.

Fueled by a surge of renters across all age ranges, rental prices nationally have grown at roughly twice the pace of average hourly wage growth, which was a paltry 2.1 percent over the past year.

One can still find galloping growth at bargain prices, but today's investors have to look farther afield.

And the bulk of that growth has been at the upper end of the market: Over the past five years, reports the Distilled Spirits Council, sales of «value» bourbon — priced below $ 15 — have grown just 13 %, while super-premium bourbons, the category that Elmer T. Lee pioneered a generation ago, are up 97.5 %.

Although Yahoo says it wants to focus on its strategic growth plan, as mentioned above, chairman Maynard Webb (great name for a digital enterprise like Yahoo) confirms that the company is also «exploring strategic alternatives,» which is code for «Please acquire us at a reasonable price.»

Each year our colleagues at MoneySense rank Canada's most promising stocks — a purely quantitative ranking that identifies high - potential companies with good prospects for growth — but that are still reasonably priced.

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

«We believe the bias for stock prices in general remains to the upside, underpinned by a growing economy, low interest rates and increasingly, cheaper oil... With operating margins at elevated levels, top line growth is poised to more quickly bleed through to the bottom line, thus supporting earnings.»

«CAPP assumes that prices will be high enough to elicit this production growth, and that transportation capacity will be there,» says Judith Dwarkin, chief energy economist at ITG Investment Research.

Indications of some slowdown in the company's growth trajectory appear to have caused some investors to lose interest, but I think that the business's prospects are underappreciated at current prices given its competitive position and favorable tailwinds.

According to a Bain analysis, 45 % of TSR growth at publicly traded global healthcare companies over the past five years came from an expansion of price - to - earnings multiples — that is more than growth from either revenue or earnings.

At the point the growth began to slow, the multiple would contract, meaning that even if its earnings do grow 600 % in the next few years, if it becomes subject to the law of big numbers - that ever increasing amounts eventually forge their own anchor - the result would be a market capitalization substantially similar to today, leading to no increase in the stock price over a long period of time.

In general, flipping homes requires at least some growth in prices in order to entice investors to pick up their game.

«They were rightly more optimistic about growth and they were less confident about inflation because they at least stopped claiming energy prices were stable.

But given the impending fruits of Pandora's growth initiatives, the disconnect between Kinder Morgan's stock price and its strong results, and Bitauto's enviable position at the center of multiple growth trends, we like their chances of doing just that.

Price growth in the GTA has accelerated sharply in recent months, suggesting that speculative forces are at work.

But anyone hoping for the kind of stock growth Shoppers enjoyed over the past decade — when its share price climbed from less than $ 18 to, at one point, over $ 55 — will be disappointed.

At this point then yes price appreciation is secondary bonus and we have an arguement of how and why Real Estate can be better than Growth Stocks in some scenarios and for some investors.